Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I like what I see and yes this company can go to 30.00 Plus.
What I have seen in selling for the last few months Endless Leaking or selling calling it as I see it. It should have gone up today to 3.00 plus. It got crushed out of the gate this morning. I also bought on what I saw was a dip. Ave price under 1.20 on 80K shares. Yes big money to me and I want to see this run.
Anyone else see the leaking of shares. Holding for the next year and hope to see it go back up and hold the line.............
EDXC Just starting to run back up. I want to see the old high. When EDXC puts out the news is should explode up. Don't want to chase this up.
Loading up here
Global Wholehealth Partners Corp.Taglich Brothers Inc
Fri, October 16, 2020, 6:30 AM PDT
NEW YORK, Oct. 16, 2020 (GLOBE NEWSWIRE) -- Taglich Brothers, Inc. announces that it has initiated coverage of Global WholeHealth Partners Corp. (OTC: GWHP).
Global WholeHealth Partners Corp., headquartered in San Clemente, CA, was founded to develop, manufacture and market in-vitro and rapid diagnostic tests with the long-term goal of being a low cost provider of infectious disease diagnostics based on molecular solutions that lessen the time to diagnose medical results and empowering healthcare professionals to make accurate decisions for patients. The company plans to produce and sell rapid diagnostic tests that include but is not limited to, Corona Viruses including COVID-19, Ebola, ZIKA, Dengue, Malaria, Influenza, and Tuberculosis.
https://finance.yahoo.com/news/taglich-brothers-initiates-coverage-global-133000741.html
EDXC is a steal at this price.
Most of your questions are in the Q's
The Name change had to revert back to EDXC Then Established CBD Unlimited as its own entity. EDXC owns 100%
https://finance.yahoo.com/news/endexx-subsidiary-cbd-unlimited-inc-123000481.html
CBD Unlimited, Inc.
Mon, October 19, 2020, 5:30 AM PDT
CAVE CREEK, AZ, Oct. 19, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire ? Endexx® Corporation (OTC: EDXC) (the “Company”), a lifestyle company focused on the intersection of science, compliance, and formulation of innovative phytonutrient-based food and nutritional products, today announced its subsidiary, CBD Unlimited™, Inc., has entered into a Joint Venture arrangement.
CBD Unlimited owns 70 percent of the Joint Venture entity and will appoint three of its five directors. CBD Unlimited will also serve as the Manager of the Joint Venture and will conduct the Joint Venture’s Business of sourcing, producing, manufacturing, marketing, distributing, and selling various Branded Products and related activities. The Joint Venture entity has also entered into a five-year Endorsement and License Agreement with a World Class Celebrity Entity.
Endexx will provide the Joint Venture entity the initial funding for the initial payments under the Endorsement and License Agreement and CBD Unlimited, Inc. is obligated to provide such funding through the Joint Venture entity. Details of the Joint Venture entity, its brand name, product category, and the celebrity endorsement will be released following the completion of various basic requisites and the new brand is ready to be released and rolled out to the market.
About Endexx
Endexx Corporation and its Division CBD Unlimited develops and distributes all-natural products from the cannabis sativa-L plant (hemp) with less than 0.01% THC. Its products range from oils, capsules, topicals, and pet products, all with the shared purpose of therapeutic and pain relief. The science behind these products involves over half a decade of research and experiments in order to perfect the accuracy in dosage and delivery of absorption per each serving.
Endexx Subsidiary CBD Unlimited, Inc. Enters into a Joint Venture Operating Agreement
CBD Unlimited, Inc.
Mon, October 19, 2020, 5:30 AM PDT
CAVE CREEK, AZ, Oct. 19, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire ? Endexx® Corporation (OTC: EDXC) (the “Company”), a lifestyle company focused on the intersection of science, compliance, and formulation of innovative phytonutrient-based food and nutritional products, today announced its subsidiary, CBD Unlimited™, Inc., has entered into a Joint Venture arrangement.
CBD Unlimited owns 70 percent of the Joint Venture entity and will appoint three of its five directors. CBD Unlimited will also serve as the Manager of the Joint Venture and will conduct the Joint Venture’s Business of sourcing, producing, manufacturing, marketing, distributing, and selling various Branded Products and related activities. The Joint Venture entity has also entered into a five-year Endorsement and License Agreement with a World Class Celebrity Entity.
Endexx will provide the Joint Venture entity the initial funding for the initial payments under the Endorsement and License Agreement and CBD Unlimited, Inc. is obligated to provide such funding through the Joint Venture entity. Details of the Joint Venture entity, its brand name, product category, and the celebrity endorsement will be released following the completion of various basic requisites and the new brand is ready to be released and rolled out to the market.
Global WholeHealth Partners Corp. (GWHP) Announces It Had Submitted an Emergency Use Authorization (EUA) Application # PEUA201789 Date 09/14/2020: for the Global Antigen CoViD19 SARS2 Rapid Test as Mentioned in the 8K Filing on 09/15/20
Global WholeHealth Partners Corp. (GWHP) announces it had submitted an Emergency Use Authorization (EUA) Application Submission Number: PEUA201789 Acknowledgement Letter date 09/14/2020: for the Global Antigen CoViD19 SARS2 Rapid Test as mentioned in the 8K filing dated September 15th, 2020.
Global WholeHealth Partners Corp. (OTC MKTS: GWHP) announced today that an application for Emergency Use Authorization (EUA) under the PreEUA is under review at the U.S. Food and Drug Administration (FDA) for Global Antigen CoViD19 SARS2 Rapid Test. Global WholeHealth Partners Corp. offers cutting edge technology using In-vitro Diagnostic (IVD) Real-Time PCR test that detects in 1 1/2 hours and the Rapid Diagnostic Testing (RDT) Whole Blood, Serum /Plasma that can detect between 15 -20 minutes, which predict diseases ahead of its industry competitors.
Mr. Charles Strongo, the Chairman and CEO of Global WholeHealth Partners Corp, said, “The Company’s goal is to offer the fastest and most reliable in-vitro diagnostic tests on the market, while keeping ahead in R&D, by offering FDA Approved Troponin I Whole Blood, Nasal Swab Influenza A & B, and Throat Swab Strep A, Urine and Saliva Drug Testing, Whole Blood Mononucleosis, H. Pylori, FOB, and several other tests.”
For international testing, which is not sold in the USA, but has a Certificate of Exportability by the FDA Certificate No. 2260-11-2019, are tests like Rapid Ebola, Rapid Dengue Fever Antibody and Antigen, Rapid Tuberculosis (TB), Rapid Malaria, and many other rapid tests. The rapid antibody test allows results to be available in 15 minutes or less. The easy to use assay develops three clear lines that confirm the assay validity and the qualitative detection and differentiation of IgM and IgG antibodies to the SARS-CoV-2 virus.
Right now, under the FDA guidelines, GWHP is selling the Covid-19 rt-qPCR Test to high complexity labs or medical institutions that qualify under the FDA guidelines as Global had partnered with 1 Drop, which has received its FDA EUA Authorization. Global is also selling the IgG/IgM Antibody Rapid Test for Covid-19 as Global has partnered with Healgen which has received its FDA EUA Authorization.
Call 1-877-568-GWHP (4947) to become a distributor or buy COVID 19 rapid test rt-qPCR kits or the Antibody IgG/IgM Rapid CoViD 19 test. We offer small sample size test kits, sold in packs of 100.
About Global WholeHealth Partners Corp.:
Global WholeHealth Partners Corp's Made In the USA Covid-19 Rapid Test Kit are manufactured in sunny San Diego, California and are suitable for the qualitative detection of SARS-CoV-2 IgM/IgG antibodies in human serum, plasma, or whole blood within 15 minutes.
By so doing, GWHP has led the fight against vector borne terminal diseases such as Ebola, ZIKA, Dengue, Malaria, Influenza and Tuberculosis, Corona Viruses, and among other vector borne diseases. Our vision is to lead the industry in infectious disease diagnostics and provide molecular solutions that lessen the time to diagnose medical results and empower healthcare professionals. For more details: https://gwhpcorp.com
Media Contact:
Name: Charles Strongo, CEO, Global WholeHealth Partners Corp.
Email: investors@gwhpcorp.com
Forward-Looking Statements
This press release contains "forward-looking statements.” Such statements may be preceded by the words "intends," "may," "will," "plans," "expects," "anticipates," "projects," "predicts," "estimates," "aims," "believes," "hopes," "potential" or similar words. Forward-looking statements are not guarantees of future performance, are based on certain assumptions and are subject to various known and unknown risks and uncertainties, many of which are beyond the Company's control, and cannot be predicted or quantified and consequently, actual results may differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties include, without limitation, risks and uncertainties associated with (i) market acceptance of our existing and new products, (ii) negative clinical trial results or lengthy product delays in key markets, (iii) an inability to secure regulatory approvals for the sale of our products, (iv) intense competition in the medical device industry from much larger, multinational companies, (v) product liability claims, (vi) product malfunctions, (vii) our limited manufacturing capabilities and reliance on subcontractors for assistance, (viii) insufficient or inadequate reimbursement by governmental and other third party payers for our products, (ix) our efforts to successfully obtain and maintain intellectual property protection covering our products, which may not be successful, (x) legislative or regulatory reform of the healthcare system in both the U.S. and foreign jurisdictions, (xi) our reliance on single suppliers for certain product components, (xii) the fact that we will need to raise additional capital to meet our business requirements in the future and that such capital raising may be costly, dilutive or difficult to obtain and (xiii) the fact that we conduct business in multiple foreign jurisdictions, exposing us to foreign currency exchange rate fluctuations, logistical and communications challenges, burdens and costs of compliance with foreign laws and political and economic instability in each jurisdiction. More detailed information about the Company and the risk factors that may affect the realization of forward looking statements is set forth in the Company's filings with the Securities and Exchange Commission (SEC), including the Company's Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q. Investors and security holders are urged to read these documents free of charge on the SEC's web site at http://www.sec.gov. The Company assumes no obligation to publicly update or revise its forward-looking statements as a result of new information, future events or otherwise.
Global WholeHealth Partners Corp. (GWHP) announces it had submitted an Emergency Use Authorization (EUA) Application Submission Number: PEUA201789 Acknowledgement Letter date 09/14/2020: for the Global Antigen CoViD19 SARS2 Rapid Test as mentioned in the 8K filing dated September 15th, 2020.
Global WholeHealth Partners Corp. (OTC MKTS: GWHP) announced today that an application for Emergency Use Authorization (EUA) under the PreEUA is under review at the U.S. Food and Drug Administration (FDA) for Global Antigen CoViD19 SARS2 Rapid Test. Global WholeHealth Partners Corp. offers cutting edge technology using In-vitro Diagnostic (IVD) Real-Time PCR test that detects in 1 1/2 hours and the Rapid Diagnostic Testing (RDT) Whole Blood, Serum /Plasma that can detect between 15 -20 minutes, which predict diseases ahead of its industry competitors.
Mr. Charles Strongo, the Chairman and CEO of Global WholeHealth Partners Corp, said, “The Company’s goal is to offer the fastest and most reliable in-vitro diagnostic tests on the market, while keeping ahead in R&D, by offering FDA Approved Troponin I Whole Blood, Nasal Swab Influenza A & B, and Throat Swab Strep A, Urine and Saliva Drug Testing, Whole Blood Mononucleosis, H. Pylori, FOB, and several other tests.”
For international testing, which is not sold in the USA, but has a Certificate of Exportability by the FDA Certificate No. 2260-11-2019, are tests like Rapid Ebola, Rapid Dengue Fever Antibody and Antigen, Rapid Tuberculosis (TB), Rapid Malaria, and many other rapid tests. The rapid antibody test allows results to be available in 15 minutes or less. The easy to use assay develops three clear lines that confirm the assay validity and the qualitative detection and differentiation of IgM and IgG antibodies to the SARS-CoV-2 virus.
Right now, under the FDA guidelines, GWHP is selling the Covid-19 rt-qPCR Test to high complexity labs or medical institutions that qualify under the FDA guidelines as Global had partnered with 1 Drop, which has received its FDA EUA Authorization. Global is also selling the IgG/IgM Antibody Rapid Test for Covid-19 as Global has partnered with Healgen which has received its FDA EUA Authorization.
Call 1-877-568-GWHP (4947) to become a distributor or buy COVID 19 rapid test rt-qPCR kits or the Antibody IgG/IgM Rapid CoViD 19 test. We offer small sample size test kits, sold in packs of 100.
About Global WholeHealth Partners Corp.:
Global WholeHealth Partners Corp's Made In the USA Covid-19 Rapid Test Kit are manufactured in sunny San Diego, California and are suitable for the qualitative detection of SARS-CoV-2 IgM/IgG antibodies in human serum, plasma, or whole blood within 15 minutes.
By so doing, GWHP has led the fight against vector borne terminal diseases such as Ebola, ZIKA, Dengue, Malaria, Influenza and Tuberculosis, Corona Viruses, and among other vector borne diseases. Our vision is to lead the industry in infectious disease diagnostics and provide molecular solutions that lessen the time to diagnose medical results and empower healthcare professionals. For more details: https://gwhpcorp.com
Media Contact:
Name: Charles Strongo, CEO, Global WholeHealth Partners Corp.
Email: investors@gwhpcorp.com
Forward-Looking Statements
This press release contains "forward-looking statements.” Such statements may be preceded by the words "intends," "may," "will," "plans," "expects," "anticipates," "projects," "predicts," "estimates," "aims," "believes," "hopes," "potential" or similar words. Forward-looking statements are not guarantees of future performance, are based on certain assumptions and are subject to various known and unknown risks and uncertainties, many of which are beyond the Company's control, and cannot be predicted or quantified and consequently, actual results may differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties include, without limitation, risks and uncertainties associated with (i) market acceptance of our existing and new products, (ii) negative clinical trial results or lengthy product delays in key markets, (iii) an inability to secure regulatory approvals for the sale of our products, (iv) intense competition in the medical device industry from much larger, multinational companies, (v) product liability claims, (vi) product malfunctions, (vii) our limited manufacturing capabilities and reliance on subcontractors for assistance, (viii) insufficient or inadequate reimbursement by governmental and other third party payers for our products, (ix) our efforts to successfully obtain and maintain intellectual property protection covering our products, which may not be successful, (x) legislative or regulatory reform of the healthcare system in both the U.S. and foreign jurisdictions, (xi) our reliance on single suppliers for certain product components, (xii) the fact that we will need to raise additional capital to meet our business requirements in the future and that such capital raising may be costly, dilutive or difficult to obtain and (xiii) the fact that we conduct business in multiple foreign jurisdictions, exposing us to foreign currency exchange rate fluctuations, logistical and communications challenges, burdens and costs of compliance with foreign laws and political and economic instability in each jurisdiction. More detailed information about the Company and the risk factors that may affect the realization of forward looking statements is set forth in the Company's filings with the Securities and Exchange Commission (SEC), including the Company's Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q. Investors and security holders are urged to read these documents free of charge on the SEC's web site at http://www.sec.gov. The Company assumes no obligation to publicly update or revise its forward-looking statements as a result of new information, future events or otherwise.
Check this news out Findit Features Members ClassWorx, Chef Paul Gerard, and Fitness Trainer Regan Patterson
https://finance.yahoo.com/news/findit-features-members-classworx-chef-154000513.html
Findit, Inc. Shows All Posts in Feeds; Findit Does Not Censor Your Posts
Friday, October 16, 2020 8:40 AM
Share this article now
Topic:
Company Update
ATLANTA, GA / ACCESSWIRE / October 16, 2020 / Findit, Inc., a Nevada Corporation (OTC PINK:FDIT) owner of Findit.com, a full-service social networking management platform and online marketing service, provides freedom of speech and does not censor member posts. In addition to Findit providing a social networking platform that allows its members to share differences of opinion without censorship (the first amendment) Findit does not have algorithms that place certain posts in front of your while not showing you other posts.
Check this news out Findit Features Members ClassWorx, Chef Paul Gerard, and Fitness Trainer Regan Patterson
https://finance.yahoo.com/news/findit-features-members-classworx-chef-154000513.html
Been adding here Holding strong as we will see all new highs soon.
Holding FDIT EDXC BSRC GWHP
EDXC is moving up slow. Hope to see it rip out into the teens soon.
Both EDXC and FDIT doing well
Last week FDIT rose up from .06 to break a new hi and pull back some.
I believe due to the market makers. See on L2 All the asks lined up for 5000 shares If the Market makers are short we may see the mother of all short squeeze's. Great things coming it you read the yahoo news boards.
Hope to see .50 by the end of the year. Doesn't matter where you buy here if it goes to 1.00 Plus
EDXC creeping upwards. FDIT hit .16 this morning
Always thought they would both run but EDXC would out perform FDIT ??
Todd time to get the company news out there and no reverse splits please.
EDXC does not need to do that. Roll up a fatty and get it moving.
NEWS & FINANCIAL REPORT:
Recent Highlights
* Secured additional distribution channels resulting in an expanded network in the pharmaceutical and grocery/natural food channels, as well as independent retailers.
* Acquired Retail Pro Associates, Inc. to expand Phyto-Bites and equine division.
* Soft-Launched orders from the company’s major global distributor and additional retailers for its high-quality hemp-derived products.
* Introduced investor outreach and ambassador program.
* Launched new product line, Phyto-Drops CBD for Pets.
* Initiated RubyBees™ Hemp Infused Honey e-commerce sales.
More to come ...
FDIT is holding .10 Hope to see a run soon to .30+
Get on before FDIT rocket takes off
Point I have if EDXC doesn't have a run soon many will dump for end of year tax losses against gains. Need to get the PR engine going and do it soon.
FDIT is now double the price of EDXC ??? . Should be a Big Wake Up Call.
Here is the link to Goldman Research Report target $11.00 on GWHP
WHAT THE HELL WHOS SELLING BOUGHT MORE TODAY THANKS
https://www.goldmanresearch.com/202008281284/Opportunity-Research/the-next-major-covid-19-player.html
Point I have if EDXC doesn't have a run soon many will dump for end of year tax losses against gains. Need to get the PR engine going and do it soon.
When FDIT is passing EDXC up in price should be a wake up call.
Bought over 1 million more down low here Thanks Boys
Ready to make a million if clear now if we get bought.
Holding Millions now and glad I bought more. I have been to the company and it wont be too long before a deal happens. All my Penny stocks will run big FDIT EDXC BSRC XMET EGOC BYOC EWLL
FDIT moving up
I think shorts are screwed. S1 coming News coming Hope to see 1.00 this year. Time to buy for sure
GWHP Looks like a break out to 20 in the morning with a very small float
Wish I bought more months ago. With all developments may see 40 near term.
Bought due to FDIT postings. Owner of FDIT for a big run as well coming
Bought 4 million at 6 today Holding 10 Million at 11
In for the long haul. Glad it got this low. What a gift to dollar cost ave Long EGOC BBRC FDIT EDXC XMET
I ADMIT I BOUGHT 2 MILLION AT .031 AND PUT A ORDER IN AT .033 BEFORE CLOSE DUE TO READING THIS BOARD AND GOT SCARED. THEY DIDNT ALL FILL AND I STILL HAVE 1.5 MILLION AT .031 MAY BUY MORE IF IT DIPS IN THE MORNING FEELING MUCH BETTER ABOUT BBRW NOW AND KNOW I GOT A GREAT DEAL
I HAVE NO PROBLEM BUYING ANOTER 2 MILL IN THE MORNING ON ANY DIP.
GOOD LUCK TO ALL. HOPE IT WORKS OUT HERE
60 million holder here trying to buy more
see you all at a nickel Holding FDIT EDXC BBRC ECOG BYOC
so happy all that bought up on the dip with a ave .0012 9 Million
SO wake me up when we hit a nickel
Holding and buying more. Trying to get 10 Million for the ride to come. Looks like BYOC is getting set up to go up fast.
Holding FDIT EDXC EGOC BYOC TCCO BSRC Millions of each
Holding and buying more. Trying to get 10 Million for the ride to silver land. Looks like the best of Daves stocks as of now ready to launch.
Holding FDIT EDXC EGOC BYOC TCCO BSRC Millions of each
The market will respond to more information from the company in the near future. Capitalize on its low price now. News will show numbers, and more certain the business developments, Positive response will be in the stock price. What you want to see is a business change-up that is so compelling that it attracts a much wider investment audience of willing buyers. The float is very low and a lot of that is now in the grips of few players Everything is looking up, higher, skyward, to the moonish
VOLUME INCREASED TODAY AND BIG BUYS ON THE ASK. SMALL FLOAT
THE COMPANY LOOKS LIKE IT READY TO TAKE OFF. I CAN SEE GWHP GOING TO 40.00 SOON WITH NEWS TRYING TO BUY MORE .
I'm 100% here to stay with my 9 million
I dont care for little swings. When EGOC pops that small investment will have a great return not to be seen in any other plays
Holding Tons of FDIT EDXC BYOC BSRC
5 Million just taken out on the ASK Wow must be a bottom.
I am holding 9 Million for .10+ Good luck all
Holding FDIT EDXC EGOC BVOC
Had buy orders filled while I was working 2 million at .0019 and 2 Million at .0014 Ave price is .016 now 4 Million Thank you all for the low buy in.
Holding EDXC FDIT BBRC EGOC Millions Just takes one to make me a millionaire
EDXC where is the Q 10 Holding EDXC to make millions and no pennies.
Ave price is .066 Not bad May add more. I see EDXC making a more to the big boards this year. Also holding BSRC, FDIT ready for short squeeze and
TCCO
FDIT is ready for a major short covering. Bid is growing and no sellers. FDIT should also go up 500% this year. I am holding the right penny stocks to make those millions. FDIT BSRC EDXC DTC low float. S1 and new app coming.
Holding 1.2 Million under 2 and didnt flip the other day as when BSRC runs it runs and may never look back. Dont want pennies Want to make a million dollars. Invested in FDIT FDIT is ready for a major short covering Bid is growing and no sellers. FDIT should also go up 500% this year. I am holding the right penny stocks to make that million. FDIT BSRC EDXC
Held My Shares not for a flip A Diet is Pain, A workout is Pain. I shower in Pain, I eat in Pain, I Sleep in Pain, Life is Pain! Sacrifice is Pain, With my stocks in Pain I can appreciate my earnings when this moons just like the rewards form all the other pain you experience don’t sell! Feel the Pain!
I will be a buyer on FDIT if it dips some more. Holding lots of shares for the big move to the big boards. Having faith this company has plan. Weak hands selling into strong hands. See you all in the teens soon.
Glad to see her come back Should have bought the bottom today but already holding 1.2 mill Under 2 So one day we will see the dollar range